CCL5 and breast carcinoma: It is well established that CC motif chemokine ligand 5 (CCL5), also called RANTES, from mesenchymal stem cells and CCL18 from tumor-associated macrophages act on breast cancer cells to enhance cancer motility, invasion and metastasis [13,14].